Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

9.4K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.4K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

18
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
18
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

24
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
24
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

19.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.1K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

22
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
22
Mitochondrial Membranes01:45

Mitochondrial Membranes

17.4K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Amino acid transporter LAT1 (SLC7A5) promotes metabolic rewiring in TNBC progression through the L-Trp/QPRT/NAD<sup>+</sup> pathway.

Journal of experimental & clinical cancer research : CR·2025
Same author

Amino acid transporter LAT1 (SLC7A5) promotes metabolic rewiring in TNBC progression through the L-Trp/QPRT/NAD<sup>+</sup> pathway.

Journal of experimental & clinical cancer research : CR·2025
Same author

Standing up for representation in undergraduate medical education curricula through medical student, librarian, and faculty collaboration: a case report.

Journal of the Medical Library Association : JMLA·2024
Same author

A Representative Clinical Course of Progression, with Molecular Insights, of Hormone Receptor-Positive, HER2-Negative Bone Metastatic Breast Cancer.

International journal of molecular sciences·2024
Same author

35th International Mammalian Genome Conference: meeting overview.

Mammalian genome : official journal of the International Mammalian Genome Society·2023
Same author

Identification of collaborative cross mouse strains permissive to Salmonella enterica serovar Typhi infection.

Scientific reports·2023

Related Experiment Video

Updated: Feb 19, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.2K

Understanding Mitochondrial Polymorphisms in Cancer.

Karen M Bussard1, Linda D Siracusa2

  • 1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania. karen.bussard@jefferson.edu.

Cancer Research
|November 4, 2017
PubMed
Summary

Mitochondrial DNA (mtDNA) alterations impact cell function and disease. This study shows mtDNA changes can alter nuclear DNA methylation and gene expression, potentially influencing disease development.

More Related Videos

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.0K
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

4.5K

Related Experiment Videos

Last Updated: Feb 19, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.2K
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.0K
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

4.5K

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Mitochondrial DNA (mtDNA) alterations, including mutations and polymorphisms, are increasingly recognized for their significant impact on cellular function and disease pathogenesis.
  • The interplay between mtDNA and nuclear DNA is crucial, particularly in cancer, necessitating a comprehensive understanding of their interactions.
  • Previous research often overlooked the profound effects of mtDNA on cellular processes.

Purpose of the Study:

  • To investigate the impact of differing nuclear and mitochondrial genomes on genome-wide nuclear DNA methylation and gene expression patterns.
  • To explore how mitochondrial DNA influences nuclear DNA alterations and gene expression.
  • To highlight the role of mtDNA alterations in cancer susceptibility, prognosis, and as potential biomarkers.

Main Methods:

  • Utilized a unique mouse model (Mitochondrial Nuclear eXchange mice) with nuclear DNA from one strain and mtDNA from another.
  • Examined genome-wide nuclear DNA methylation patterns in brain tissue.
  • Analyzed gene expression patterns in brain tissue.

Main Results:

  • Demonstrated that alterations in mitochondrial DNA drove significant changes in nuclear DNA expression.
  • Observed alterations in nuclear DNA methylation patterns influenced by the mitochondrial genome.
  • These mtDNA-driven changes in nuclear DNA may have implications for disease pathogenesis.

Conclusions:

  • Mitochondrial DNA plays a critical role in regulating nuclear DNA methylation and gene expression.
  • mtDNA alterations can profoundly affect cellular function and contribute to disease.
  • Further research into mtDNA's role in cancer progression, including its potential as a biomarker, is warranted.